These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20029936)

  • 1. That instrument is lousy! In search of agreement when using instrumental variables estimation in substance use research.
    French MT; Popovici I
    Health Econ; 2011 Feb; 20(2):127-46. PubMed ID: 20029936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of instrumental variables for endogenous treatment at the provider level.
    Konetzka RT; Yang F; Werner RM
    Health Econ; 2019 May; 28(5):710-716. PubMed ID: 30672042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling for the endogeneity of peer substance use on adolescent alcohol and tobacco use.
    Norton EC; Lindrooth RC; Ennett ST
    Health Econ; 1998 Aug; 7(5):439-53. PubMed ID: 9753378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The productivity of mental health care: an instrumental variable approach.
    Lu M
    J Ment Health Policy Econ; 1999 Jun; 2(2):59-71. PubMed ID: 11967410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instrumental variables estimation under a structural Cox model.
    Martinussen T; Nørbo Sørensen D; Vansteelandt S
    Biostatistics; 2019 Jan; 20(1):65-79. PubMed ID: 29165631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis.
    Pence BW; Miller WC; Gaynes BN
    Psychol Assess; 2009 Jun; 21(2):235-9. PubMed ID: 19485679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations.
    Gjersing L; Caplehorn JR; Clausen T
    BMC Med Res Methodol; 2010 Feb; 10():13. PubMed ID: 20144247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional studies - what are they good for?
    Kesmodel US
    Acta Obstet Gynecol Scand; 2018 Apr; 97(4):388-393. PubMed ID: 29453895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in the reporting and conduct of instrumental variable studies: a systematic review.
    Davies NM; Smith GD; Windmeijer F; Martin RM
    Epidemiology; 2013 May; 24(3):363-9. PubMed ID: 23532055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study.
    Carrà G; Crocamo C; Borrelli P; Tabacchi T; Bartoli F; Popa I; Montomoli C; Clerici M
    Subst Use Misuse; 2017 Mar; 52(4):451-458. PubMed ID: 27849429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis.
    Moberg CA; Humphreys K
    Drug Alcohol Rev; 2017 May; 36(3):378-388. PubMed ID: 27324921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women and addiction: the importance of gender issues in substance abuse research.
    Tuchman E
    J Addict Dis; 2010 Apr; 29(2):127-38. PubMed ID: 20407972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in substance use disorders.
    Brady KT; Randall CL
    Psychiatr Clin North Am; 1999 Jun; 22(2):241-52. PubMed ID: 10385931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation analysis with zero-inflated substance use outcomes: Challenges and recommendations.
    O'Rourke HP; Vazquez E
    Addict Behav; 2019 Jul; 94():16-25. PubMed ID: 30824126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and utility of community health workers' estimation of kava use.
    Clough AR; Baille R; Burns CB; Guyula T; Wunungmurra R; Wanybarrnga SR
    Aust N Z J Public Health; 2002 Feb; 26(1):52-7. PubMed ID: 11895027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Stage Residual Inclusion Estimation in Health Services Research and Health Economics.
    Terza JV
    Health Serv Res; 2018 Jun; 53(3):1890-1899. PubMed ID: 28568477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the Heteroskedastic Canonical Contagion Model with Instrumental Variables.
    Ribeiro AL; Hotta LK
    PLoS One; 2016; 11(12):e0168967. PubMed ID: 28030628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of a questionnaire on substance use among adolescent students, Brazil.
    Machado Neto Ade S; Andrade TM; Fernandes GB; Zacharias HP; Carvalho FM; Machado AP; Dias AC; Garcia AC; Santana LR; Rolin CE; Sampaio C; Ghiraldi G; Bastos FI
    Rev Saude Publica; 2010 Oct; 44(5):830-9. PubMed ID: 20877921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.